Evidence map›Paper›PMID 26091543›Full record

ArticleScientific reports2015

Violacein as a genetically-controlled, enzymatically amplified and photobleaching-resistant chromophore for optoacoustic bacterial imaging.

Yuanyuan Jiang, Felix Sigmund, Josefine Reber, Xosé Luís Deán-Ben, Sarah Glasl, Moritz Kneipp, Héctor Estrada, Daniel Razansky, Vasilis Ntziachristos, Gil G Westmeyer

Abstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Bacteria-Based Living Probes: Preparation and the Applications in Bioimaging and Diagnosis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yuanyuan Jiang1] Institute for Biological and Medical Imaging (IBMI), Helmholtz Zentrum München, Neuherberg, Germany [2] Institute of Developmental Genetics (IDG), Helmholtz Zentrum München, Neuherberg, Germany.
Felix Sigmund1] Institute for Biological and Medical Imaging (IBMI), Helmholtz Zentrum München, Neuherberg, Germany [2] Institute of Developmental Genetics (IDG), Helmholtz Zentrum München, Neuherberg, Germany.
Josefine ReberInstitute for Biological and Medical Imaging (IBMI), Helmholtz Zentrum München, Neuherberg, Germany.
Xosé Luís Deán-BenInstitute for Biological and Medical Imaging (IBMI), Helmholtz Zentrum München, Neuherberg, Germany.
Sarah GlaslInstitute for Biological and Medical Imaging (IBMI), Helmholtz Zentrum München, Neuherberg, Germany.
Moritz Kneipp1] Institute for Biological and Medical Imaging (IBMI), Helmholtz Zentrum München, Neuherberg, Germany [2] Chair for Biological Imaging, Technische Universität München (TUM), Munich, Germany.
Héctor EstradaInstitute for Biological and Medical Imaging (IBMI), Helmholtz Zentrum München, Neuherberg, Germany.
Daniel Razansky1] Institute for Biological and Medical Imaging (IBMI), Helmholtz Zentrum München, Neuherberg, Germany [2] Chair for Biological Imaging, Technische Universität München (TUM), Munich, Germany.
Vasilis Ntziachristos1] Institute for Biological and Medical Imaging (IBMI), Helmholtz Zentrum München, Neuherberg, Germany [2] Chair for Biological Imaging, Technische Universität München (TUM), Munich, Germany.
Gil G Westmeyer1] Institute for Biological and Medical Imaging (IBMI), Helmholtz Zentrum München, Neuherberg, Germany [2] Institute of Developmental Genetics (IDG), Helmholtz Zentrum München, Neuherberg, Germany [3] Department of Nuclear Medicine, Technische Universität München (TUM), Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is growing interest in genetically expressed reporters for in vivo studies of bacterial colonization in the context of infectious disease research, studies of the bacterial microbiome or cancer imaging and treatment. To empower non-invasive high-resolution bacterial tracking with deep tissue penetration, we herein use the genetically controlled biosynthesis of the deep-purple pigment Violacein as a photobleaching-resistant chromophore label for in vivo optoacoustic (photoacoustic) imaging in the near-infrared range. We demonstrate that Violacein-producing bacteria can be imaged with high contrast-to-noise in strongly vascularized xenografted murine tumors and further observe that Violacein shows anti-tumoral activity. Our experiments thus identify Violacein as a robust bacterial label for non-invasive optoacoustic imaging with high potential for basic research and future theranostic applications in bacterial tumor targeting.

Indexed as

Bacterial ProteinsEscherichia coliChromobacteriumIndolesMolecular ImagingPhotoacoustic TechniquesBacterial ProteinsIndolesviolacein

Identifiers

PMID26091543
PMCPMC4473533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.